Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 13 | 2026 | 287 | 3.840 |
Why?
|
| Hypothalamic Diseases | 5 | 2026 | 40 | 1.830 |
Why?
|
| Hamartoma | 5 | 2026 | 49 | 1.830 |
Why?
|
| Deep Brain Stimulation | 5 | 2026 | 446 | 1.540 |
Why?
|
| Epilepsy | 6 | 2026 | 876 | 1.140 |
Why?
|
| Laser Therapy | 7 | 2025 | 243 | 1.080 |
Why?
|
| Electric Stimulation Therapy | 2 | 2026 | 91 | 1.070 |
Why?
|
| Tuberous Sclerosis | 3 | 2025 | 147 | 1.060 |
Why?
|
| Vagus Nerve Stimulation | 3 | 2024 | 65 | 1.040 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 166 | 0.570 |
Why?
|
| Seizures | 7 | 2026 | 890 | 0.570 |
Why?
|
| Stereotaxic Techniques | 3 | 2025 | 102 | 0.430 |
Why?
|
| Treatment Outcome | 12 | 2026 | 12936 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2026 | 3763 | 0.380 |
Why?
|
| Child, Preschool | 12 | 2026 | 15110 | 0.340 |
Why?
|
| Young Adult | 9 | 2026 | 10103 | 0.330 |
Why?
|
| Child | 13 | 2026 | 26341 | 0.300 |
Why?
|
| Adolescent | 10 | 2026 | 20987 | 0.270 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17753 | 0.210 |
Why?
|
| Humans | 22 | 2026 | 131163 | 0.210 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 19 | 0.210 |
Why?
|
| Electroencephalography | 2 | 2025 | 863 | 0.200 |
Why?
|
| Vocal Cord Paralysis | 1 | 2024 | 68 | 0.200 |
Why?
|
| Drug Hypersensitivity | 1 | 2024 | 101 | 0.190 |
Why?
|
| Laryngoscopy | 1 | 2024 | 128 | 0.190 |
Why?
|
| Hemispherectomy | 1 | 2023 | 28 | 0.190 |
Why?
|
| Male | 14 | 2026 | 64957 | 0.180 |
Why?
|
| Female | 14 | 2026 | 70963 | 0.180 |
Why?
|
| Verbal Learning | 1 | 2022 | 67 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2024 | 363 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1490 | 0.170 |
Why?
|
| Philadelphia Chromosome | 1 | 2021 | 41 | 0.170 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2021 | 21 | 0.170 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 103 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 344 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2020 | 240 | 0.150 |
Why?
|
| Memory | 1 | 2022 | 314 | 0.150 |
Why?
|
| Infant | 6 | 2025 | 13352 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2025 | 5063 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2026 | 3147 | 0.130 |
Why?
|
| Bell Palsy | 1 | 2014 | 6 | 0.100 |
Why?
|
| Quality of Life | 1 | 2024 | 2082 | 0.100 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 29 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 41 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1586 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 31282 | 0.080 |
Why?
|
| Disease Management | 2 | 2026 | 558 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2026 | 122 | 0.060 |
Why?
|
| Magnetoencephalography | 1 | 2025 | 44 | 0.060 |
Why?
|
| Kentucky | 1 | 2024 | 29 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2025 | 180 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2026 | 283 | 0.050 |
Why?
|
| Dysphonia | 1 | 2024 | 16 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5196 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2024 | 61 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 140 | 0.050 |
Why?
|
| Electrocorticography | 1 | 2023 | 54 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 260 | 0.040 |
Why?
|
| Imatinib Mesylate | 1 | 2021 | 47 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2021 | 27 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2026 | 1240 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 258 | 0.040 |
Why?
|
| Karyotyping | 1 | 2021 | 308 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 85 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 743 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2304 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 28601 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 960 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2018 | 30 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2021 | 446 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 587 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2024 | 844 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3360 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 633 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 371 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3359 | 0.030 |
Why?
|
| Hydroxycorticosteroids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1826 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3175 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1267 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21025 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4886 | 0.010 |
Why?
|